Is Enliven Therapeutics, Inc. (ELVN) a Buy, Sell, or Hold?
Enliven Therapeutics, Inc.
NASDAQ:ELVN
$51.73 USD
$0.86 (1.69%)
- Volume
- 749.92K
- Average Volume
- 1.33M
- Market Capitalization
- $3.7B
- P/E Ratio
- -31.54
- Dividend Yield
- 0.00%
- Price Target
- $65.00
- Year High
- $52.39
- Year Low
- $14.79
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $40.32
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
29
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
66
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ 1.8M
ELVN Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
ELVN Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Kunkel Lori Anne | director | 2026-07-06 | S-Sale | 49.9834 | 2026-07-08 |
| Kunkel Lori Anne | director | 2026-07-06 | S-Sale | 50.8442 | 2026-07-08 |
| ORBIMED ADVISORS LLC | 10 percent owner | 2026-06-22 | S-Sale | 45.38 | 2026-06-24 |
| ORBIMED ADVISORS LLC | 10 percent owner | 2026-06-22 | S-Sale | 45 | 2026-06-24 |
| ORBIMED ADVISORS LLC | 10 percent owner | 2026-06-22 | S-Sale | 45.38 | 2026-06-24 |
| ORBIMED ADVISORS LLC | 10 percent owner | 2026-06-22 | S-Sale | 45 | 2026-06-24 |
| Hohl Benjamin | officer: CHIEF FINANCIAL OFFICER | 2026-06-17 | M-Exempt | 2.48 | 2026-06-22 |
| Hohl Benjamin | officer: CHIEF FINANCIAL OFFICER | 2026-06-17 | M-Exempt | 2.48 | 2026-06-22 |
| Hohl Benjamin | officer: CHIEF FINANCIAL OFFICER | 2026-06-17 | S-Sale | 42.785 | 2026-06-22 |
| Hohl Benjamin | officer: CHIEF FINANCIAL OFFICER | 2026-06-17 | S-Sale | 43.8634 | 2026-06-22 |
| Hohl Benjamin | officer: CHIEF FINANCIAL OFFICER | 2026-06-17 | S-Sale | 44.7475 | 2026-06-22 |
| Collins Helen Louise | officer: CHIEF MEDICAL OFFICER | 2026-06-17 | M-Exempt | 2.48 | 2026-06-22 |
| Collins Helen Louise | officer: CHIEF MEDICAL OFFICER | 2026-06-17 | M-Exempt | 2.48 | 2026-06-22 |
| Collins Helen Louise | officer: CHIEF MEDICAL OFFICER | 2026-06-17 | S-Sale | 42.827 | 2026-06-22 |
| Collins Helen Louise | officer: CHIEF MEDICAL OFFICER | 2026-06-17 | S-Sale | 43.8701 | 2026-06-22 |
| Collins Helen Louise | officer: CHIEF MEDICAL OFFICER | 2026-06-17 | S-Sale | 44.743 | 2026-06-22 |
| ORBIMED ADVISORS LLC | 10 percent owner | 2026-06-15 | S-Sale | 45.02 | 2026-06-17 |
| ORBIMED ADVISORS LLC | 10 percent owner | 2026-06-15 | S-Sale | 45.02 | 2026-06-17 |
| Kunkel Lori Anne | director | 2026-06-05 | S-Sale | 34.2794 | 2026-06-09 |
| Kunkel Lori Anne | director | 2026-06-05 | S-Sale | 35.3573 | 2026-06-09 |
| Kunkel Lori Anne | director | 2026-06-05 | S-Sale | 35.8187 | 2026-06-09 |
| Collins Helen Louise | officer: CHIEF MEDICAL OFFICER | 2026-05-18 | M-Exempt | 2.48 | 2026-05-20 |
| Collins Helen Louise | officer: CHIEF MEDICAL OFFICER | 2026-05-18 | M-Exempt | 2.48 | 2026-05-20 |
| Collins Helen Louise | officer: CHIEF MEDICAL OFFICER | 2026-05-18 | S-Sale | 39.534 | 2026-05-20 |
| Collins Helen Louise | officer: CHIEF MEDICAL OFFICER | 2026-05-18 | S-Sale | 40.2473 | 2026-05-20 |
| Collins Helen Louise | officer: CHIEF MEDICAL OFFICER | 2026-05-18 | S-Sale | 41.2052 | 2026-05-20 |
| Collins Helen Louise | officer: CHIEF MEDICAL OFFICER | 2026-04-17 | M-Exempt | 2.48 | 2026-04-21 |
| Collins Helen Louise | officer: CHIEF MEDICAL OFFICER | 2026-04-17 | M-Exempt | 2.48 | 2026-04-21 |
| Collins Helen Louise | officer: CHIEF MEDICAL OFFICER | 2026-04-17 | S-Sale | 45.8107 | 2026-04-21 |
| Collins Helen Louise | officer: CHIEF MEDICAL OFFICER | 2026-04-17 | S-Sale | 47.3896 | 2026-04-21 |
| Collins Helen Louise | officer: CHIEF MEDICAL OFFICER | 2026-04-17 | S-Sale | 48.0555 | 2026-04-21 |
| Collins Helen Louise | officer: CHIEF MEDICAL OFFICER | 2026-03-25 | M-Exempt | 2.48 | 2026-03-27 |
| Collins Helen Louise | officer: CHIEF MEDICAL OFFICER | 2026-03-25 | M-Exempt | 2.48 | 2026-03-27 |
| Collins Helen Louise | officer: CHIEF MEDICAL OFFICER | 2026-03-25 | S-Sale | 35.1006 | 2026-03-27 |
| Collins Helen Louise | officer: CHIEF MEDICAL OFFICER | 2026-03-17 | M-Exempt | 2.48 | 2026-03-19 |
| Collins Helen Louise | officer: CHIEF MEDICAL OFFICER | 2026-03-17 | M-Exempt | 2.48 | 2026-03-19 |
| Collins Helen Louise | officer: CHIEF MEDICAL OFFICER | 2026-03-17 | S-Sale | 27.76 | 2026-03-19 |
| Collins Helen Louise | officer: CHIEF MEDICAL OFFICER | 2026-03-09 | M-Exempt | 2.48 | 2026-03-11 |
| Collins Helen Louise | officer: CHIEF MEDICAL OFFICER | 2026-03-10 | M-Exempt | 2.48 | 2026-03-11 |
| Collins Helen Louise | officer: CHIEF MEDICAL OFFICER | 2026-03-09 | M-Exempt | 2.48 | 2026-03-11 |
| Collins Helen Louise | officer: CHIEF MEDICAL OFFICER | 2026-03-10 | M-Exempt | 2.48 | 2026-03-11 |
| Collins Helen Louise | officer: CHIEF MEDICAL OFFICER | 2026-03-10 | S-Sale | 30.1932 | 2026-03-11 |
| Collins Helen Louise | officer: CHIEF MEDICAL OFFICER | 2026-03-09 | S-Sale | 30.0228 | 2026-03-11 |
| Hohl Benjamin | officer: CHIEF FINANCIAL OFFICER | 2026-03-06 | S-Sale | 29.5839 | 2026-03-10 |
| Heyman Richard A. | director | 2026-02-17 | S-Sale | 26.1759 | 2026-02-19 |
| Collins Helen Louise | officer: CHIEF MEDICAL OFFICER | 2026-02-17 | M-Exempt | 2.48 | 2026-02-19 |
| Collins Helen Louise | officer: CHIEF MEDICAL OFFICER | 2026-02-17 | M-Exempt | 2.48 | 2026-02-19 |
| Collins Helen Louise | officer: CHIEF MEDICAL OFFICER | 2026-02-17 | S-Sale | 26.1747 | 2026-02-19 |
| Kunkel Lori Anne | director | 2026-02-12 | A-Award | 27.16 | 2026-02-17 |
| Heyman Richard A. | director | 2026-02-12 | A-Award | 27.16 | 2026-02-17 |
| Gupta Rishi | director | 2026-02-12 | A-Award | 27.16 | 2026-02-17 |
| Gupta Rishi | director | 2026-02-12 | A-Award | 27.16 | 2026-02-17 |
| Garland J. Scott | director | 2026-02-12 | A-Award | 27.16 | 2026-02-17 |
| Derynck Mika K | director | 2026-02-12 | A-Award | 27.16 | 2026-02-17 |
| Bauer Jake | director | 2026-02-12 | A-Award | 27.16 | 2026-02-17 |
| Ballal Rahul D. | director | 2026-02-12 | A-Award | 27.16 | 2026-02-17 |
| Patel Anish | officer: CHIEF OPERATING OFFICER | 2026-02-12 | A-Award | 27.16 | 2026-02-17 |
| Patel Anish | officer: CHIEF OPERATING OFFICER | 2026-02-12 | A-Award | 0 | 2026-02-17 |
| Lyssikatos Joseph P | officer: CHIEF SCIENTIFIC OFFICER | 2026-02-12 | A-Award | 27.16 | 2026-02-17 |
| Lyssikatos Joseph P | officer: CHIEF SCIENTIFIC OFFICER | 2026-02-12 | A-Award | 0 | 2026-02-17 |
| Hohl Benjamin | officer: CHIEF FINANCIAL OFFICER | 2026-02-12 | A-Award | 27.16 | 2026-02-17 |
| Hohl Benjamin | officer: CHIEF FINANCIAL OFFICER | 2026-02-12 | A-Award | 0 | 2026-02-17 |
| Collins Helen Louise | officer: CHIEF MEDICAL OFFICER | 2026-02-12 | A-Award | 27.16 | 2026-02-17 |
| Collins Helen Louise | officer: CHIEF MEDICAL OFFICER | 2026-02-12 | A-Award | 0 | 2026-02-17 |
| Lyssikatos Joseph P | officer: CHIEF SCIENTIFIC OFFICER | 2026-02-06 | S-Sale | 29.0438 | 2026-02-10 |
| Lyssikatos Joseph P | officer: CHIEF SCIENTIFIC OFFICER | 2026-01-20 | S-Sale | 26.373 | 2026-01-22 |
| Lyssikatos Joseph P | officer: CHIEF SCIENTIFIC OFFICER | 2026-01-20 | S-Sale | 26.8995 | 2026-01-22 |
| Heyman Richard A. | director | 2026-01-20 | S-Sale | 26.4592 | 2026-01-22 |
| Heyman Richard A. | director | 2026-01-20 | S-Sale | 26.956 | 2026-01-22 |
| Patel Anish | officer: CHIEF OPERATING OFFICER | 2026-01-09 | S-Sale | 27.9842 | 2026-01-13 |
| Patel Anish | officer: CHIEF OPERATING OFFICER | 2026-01-09 | S-Sale | 28.5 | 2026-01-13 |
| Lyssikatos Joseph P | officer: CHIEF SCIENTIFIC OFFICER | 2026-01-08 | S-Sale | 20.1282 | 2026-01-12 |
| Lyssikatos Joseph P | officer: CHIEF SCIENTIFIC OFFICER | 2026-01-08 | S-Sale | 24.9238 | 2026-01-12 |
| Lyssikatos Joseph P | officer: CHIEF SCIENTIFIC OFFICER | 2026-01-09 | S-Sale | 24.9008 | 2026-01-12 |
| Lyssikatos Joseph P | officer: CHIEF SCIENTIFIC OFFICER | 2026-01-09 | S-Sale | 29.1343 | 2026-01-12 |
| Heyman Richard A. | director | 2026-01-08 | S-Sale | 25.035 | 2026-01-12 |
| Heyman Richard A. | director | 2026-01-08 | S-Sale | 25 | 2026-01-12 |
| Heyman Richard A. | director | 2026-01-09 | S-Sale | 25.0001 | 2026-01-12 |
| Garland J. Scott | director | 2026-01-07 | A-Award | 15.47 | 2026-01-09 |
| Garland J. Scott | director | 2026-01-07 | 22.47 | 2026-01-09 | |
| Garland J. Scott | director | 2026-01-07 | 24.12 | 2026-01-09 | |
| Hohl Benjamin | officer: CHIEF FINANCIAL OFFICER | 2025-12-22 | M-Exempt | 2.48 | 2025-12-23 |
| Hohl Benjamin | officer: CHIEF FINANCIAL OFFICER | 2025-12-22 | M-Exempt | 2.48 | 2025-12-23 |
| Lyssikatos Joseph P | officer: CHIEF SCIENTIFIC OFFICER | 2025-12-19 | S-Sale | 16.8412 | 2025-12-23 |
| Kunkel Lori Anne | director | 2025-12-17 | M-Exempt | 1.12 | 2025-12-19 |
| Kunkel Lori Anne | director | 2025-12-17 | M-Exempt | 1.12 | 2025-12-19 |
| Fair Richard A. | director, officer: PRESIDENT AND CEO | 2025-12-11 | A-Award | 18.77 | 2025-12-12 |
| Fair Richard A. | 2025-12-11 | 0 | 2025-12-12 | ||
| Patel Anish | officer: CHIEF OPERATING OFFICER | 2025-12-08 | S-Sale | 20.7622 | 2025-12-10 |
| Patel Anish | officer: CHIEF OPERATING OFFICER | 2025-12-08 | S-Sale | 21.7794 | 2025-12-10 |
| Lyssikatos Joseph P | officer: CHIEF SCIENTIFIC OFFICER | 2025-11-19 | S-Sale | 22.3013 | 2025-11-21 |
| Lyssikatos Joseph P | officer: CHIEF SCIENTIFIC OFFICER | 2025-11-19 | S-Sale | 23.091 | 2025-11-21 |
| Kintz Samuel | director, officer: PRESIDENT AND CEO | 2025-11-17 | S-Sale | 21.8191 | 2025-11-19 |
| Patel Anish | officer: CHIEF OPERATING OFFICER | 2025-11-07 | S-Sale | 17.3503 | 2025-11-12 |
| Patel Anish | officer: CHIEF OPERATING OFFICER | 2025-11-07 | S-Sale | 17.9371 | 2025-11-12 |
| Lyssikatos Joseph P | officer: CHIEF SCIENTIFIC OFFICER | 2025-10-20 | S-Sale | 22.082 | 2025-10-22 |
| Kintz Samuel | director, officer: PRESIDENT AND CEO | 2025-10-17 | S-Sale | 21.3323 | 2025-10-21 |
| Patel Anish | officer: CHIEF OPERATING OFFICER | 2025-10-07 | S-Sale | 20.0979 | 2025-10-09 |
| Hohl Benjamin | officer: CHIEF FINANCIAL OFFICER | 2025-09-29 | M-Exempt | 2.48 | 2025-10-01 |
| Hohl Benjamin | officer: CHIEF FINANCIAL OFFICER | 2025-09-29 | M-Exempt | 2.48 | 2025-10-01 |